Gene · 822
Papers1,865
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 1,865
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Perfluoroalkyl substances (PFASs) decrease the expression of recombination-activating genes (RAG1 and RAG2) in human B lymphoma Namalwa cells. | Arch Toxicol | 2022 | 36326898 | PubTator, text mining | PubMed |
| Chemotherapy-induced peripheral neuropathy in children and adolescent cancer patients. | Front Mol Biosci | 2022 | 36310587 | PubTator, text mining | PubMed |
| Near-atomic, non-icosahedrally averaged structure of giant virus Paramecium bursaria chlorella virus 1. | Nat Commun | 2022 | 36309542 | PubTator, text mining | PubMed |
| Heterogeneity of treatment effect of interferon-β1b and lopinavir-ritonavir in patients with Middle East respiratory syndrome by cytokine levels. | Sci Rep | 2022 | 36307462 | PubTator, text mining | PubMed |
Infectious spleen and kidney necrosis virus induces the reactive oxidative species/Nrf2-mediated oxidative stress response for the regulation of mitochondrion-mediated Bax/Bak cell death signals in GF-1 cells. | Front Microbiol | 2022 | 36304944 | PubTator, text mining | PubMed |
| Temporal proteomic analyses of human lung cells distinguish high pathogenicity influenza viruses and coronaviruses from low pathogenicity viruses. | Front Microbiol | 2022 | 36299731 | PubTator, text mining | PubMed |
| Identifying Hub Genes Associated with Neoadjuvant Chemotherapy Resistance in Breast Cancer and Potential Drug Repurposing for the Development of Precision Medicine. | Int J Mol Sci | 2022 | 36293493 | PubTator, text mining | PubMed |
| Scinderin Is a Novel Oncogene for Its Correlates with Poor Prognosis, Immune Infiltrates and Matrix Metalloproteinase-2/9 (MMP2/9) in Glioma. | Brain Sci | 2022 | 36291348 | PubTator, text mining | PubMed |
| Potential of Disease-Modifying Anti-Rheumatic Drugs to Limit Abdominal Aortic Aneurysm Growth. | Biomedicines | 2022 | 36289670 | PubTator, text mining | PubMed |
| Dephosphorylation in nuclear reassembly after mitosis. | Front Cell Dev Biol | 2022 | 36268509 | PubTator, text mining | PubMed |
| CapG promoted nasopharyngeal carcinoma cell motility involving Rho motility pathway independent of ROCK. | World J Surg Oncol | 2022 | 36258216 | PubTator, text mining | PubMed |
| Identification of the Key Genes Involved in the Tumorigenesis and Prognosis of Prostate Cancer. | Comput Math Methods Med | 2022 | 36245843 | PubTator, text mining | PubMed |
| CAPG facilitates diffuse large B-cell lymphoma cell progression through PI3K/AKT signaling pathway. | Hum Immunol | 2022 | 36244872 | PubTator, text mining | PubMed |
| Development of a Hallmark Pathway-Related Gene Signature Associated with Immune Response for Lower Grade Gliomas. | Int J Mol Sci | 2022 | 36233273 | PubTator, text mining | PubMed |
| Promyelocytic Leukemia Protein Potently Restricts Human Cytomegalovirus Infection in Endothelial Cells. | Int J Mol Sci | 2022 | 36233232 | PubTator, text mining | PubMed |
| Differential Intracellular Protein Distribution in Cancer and Normal Cells-Beta-Catenin and CapG in Gynecologic Malignancies. | Cancers (Basel) | 2022 | 36230711 | PubTator, text mining | PubMed |
| Comprehensive analysis reveals potential hub genes and therapeutic drugs in an acquired lymphedema model. | Gland Surg | 2022 | 36221279 | PubTator, text mining | PubMed |
| Identification of Prognostic Markers and Potential Therapeutic Targets in Gastric Adenocarcinoma by Machine Learning Based on mRNAsi Index. | J Oncol | 2022 | 36213825 | PubTator, text mining | PubMed |
| Exploration of Predictive Biomarkers for Postoperative Recurrence in Chronic Rhinosinusitis with Nasal Polyps Based on Serum Multiple-Cytokine Profiling. | Mediators Inflamm | 2022 | 36211987 | PubTator, text mining | PubMed |
| Single-nucleus RNA sequencing reveals the shared mechanisms inducing cognitive impairment between COVID-19 and Alzheimer's disease. | Front Immunol | 2022 | 36211330 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/822/papers?page=19